Afluria Market Report 2026
Afluria Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Afluria Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Afluria Market Overview

• The Afluria market growth in the historic period has been driven by recurring seasonal influenza outbreaks, public health vaccination policies

• Market expansion is supported by growth in preventive healthcare awareness, increasing vaccination coverage targets

• Growth Driver: Rising Influenza Prevalence Boosts Afluria Vaccine Market Growth

• Market Trend: Innovative Solutions In The Influenza Vaccine Market Enhanced Growth

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Afluria Market?

Afluria is an inactivated influenza vaccine designed to protect against infections caused by specific strains of the influenza virus. Approved for individuals aged 6 months and older, it is administered via injection and helps stimulate the immune system to produce antibodies. Annual vaccination is recommended to ensure effective protection against seasonal flu outbreaks.

The main formulations of afluria are pre-filled syringes and multi-dose vials. Pre-filled syringes offer a single-dose option for flu vaccines, ensuring accuracy and ease of use. They are commonly used in outpatient clinics and pharmacies to streamline administration. These syringes reduce contamination risk and support efficient immunization efforts. The clinical indication includes Influenza Prevention and is distributed through hospitals and clinics, retail pharmacies, and government suppliers and utilized by end users such as pediatric, adult, and geriatric.

Afluria Market Global Report 2026 Market Report bar graph

What Is The Afluria Market Size and Share 2026?

The growth in the historic period can be attributed to recurring seasonal influenza outbreaks, public health vaccination policies, hospital-based immunization programs, rising infection-related hospitalizations, established vaccine manufacturing platforms.

What Is The Afluria Market Growth Forecast?

The growth in the forecast period can be attributed to growth in preventive healthcare awareness, increasing vaccination coverage targets, expansion of retail pharmacy immunization, improved cold chain logistics, rising geriatric population. Major trends in the forecast period include rising demand for seasonal influenza vaccination, expansion of adult and pediatric immunization programs, increased focus on preventive healthcare, growth in government-supported vaccination campaigns, improved vaccine distribution infrastructure.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Afluria Market Segmentation

1) By Formulation: Pre-Filled Syringes, Multi-Dose Vials

2) By Clinical Indication: Influenza Prevention

3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Government Supplier

4) By End Users: Pediatric, Adult, Geriatric

What Are The Drivers Of The Afluria Market?

The growing prevalence of influenza is expected to propel the growth of the afluria market going forward. Influenza, commonly known as the flu, is an infectious respiratory disease caused by influenza viruses that can lead to mild to severe illness, with symptoms including fever, cough, sore throat, body aches, and fatigue. The increasing prevalence of influenza is attributed to factors such as heightened public awareness of the disease, rising incidence rates from virus mutations, and greater demand for vaccinations, especially among vulnerable groups like the elderly. Afluria is used as a vaccine to prevent influenza by stimulating the immune system to produce antibodies against the flu virus. For instance, in November 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, as of October 16, 2024, influenza positivity rose to 2.3% in week 41, up from 2% the previous week, with the highest rates (5.1%) seen in those aged 5 to 14 years. Therefore, the growing prevalence of influenza is driving the growth of the afluria industry.

The growing geriatric population is expected to propel the growth of the afluria market going forward. The geriatric population refers to individuals who are typically aged 65 and older and characterized by unique health needs and challenges associated with aging. The geriatric population is growing due to a combination of declining fertility rates and increasing life expectancy, resulting in a larger proportion of older individuals within the overall population. The geriatric population, which is particularly vulnerable to severe illness and mortality from influenza, necessitates effective vaccination strategies such as afluria to protect older adults and reduce flu-related health complications. For instance, in July 2024, according to a report published by the House of Commons Library, a UK-based government agency, the UK's population is aging, with around 12.7 million people aged 65 and over in 2022, accounting for 19% of the total population, and this number is expected to rise to 22.1 million, or 27% of the population, by 2072. Therefore, the growing geriatric population is driving the growth of the afluria industry.

Key Players In The Global Afluria Market

Major companies operating in the afluria market are CSL Seqirus

Global Afluria Market Trends and Insights

Major companies operating in the afluria market are focusing on developing innovative solutions such as nano-sized particle-based vaccines to enhance vaccine efficacy, stability, and targeted delivery. A nanoparticle-based vaccine refers to a formulation that uses ultra-small particles in the nanometer range to deliver antigens more efficiently and strengthen immune response. For instance, in March 2024, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched the Cadiflu Tetra Vaccine, an advanced quadrivalent influenza vaccine designed to prevent seasonal influenza. The vaccine targets four influenza virus strains, including subtypes A and B, and integrates key proteins such as hemagglutinin (HA), neuraminidase (NA), and matrix 1 (M1) in a single formulation. This approach offers broader protection, improved immunogenicity, and a superior safety profile compared to traditional influenza vaccines.

Need data on a specific region in this market?

Regional Insights

North America was the largest region in the afluria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Afluria Market?

The afluria market consists of sales of afluria quadrivalent, and afluria trivalent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Afluria Market Report 2026?

The afluria market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the afluria industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Afluria Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Formulation, Clinical Indication, Distribution Channel, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled CSL Seqirus
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Afluria Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Afluria Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Afluria Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Afluria Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Demand For Seasonal Influenza Vaccination

4.2.2 Expansion Of Adult And Pediatric Immunization Programs

4.2.3 Increased Focus On Preventive Healthcare

4.2.4 Growth In Government-Supported Vaccination Campaigns

4.2.5 Improved Vaccine Distribution Infrastructure

5. Afluria Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Retail Pharmacies

5.4 Public Health Centers

5.5 Vaccination Programs

6. Afluria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Afluria Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Afluria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Afluria Market Size, Comparisons And Growth Rate Analysis

7.3. Global Afluria Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Afluria Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Afluria Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Afluria Market Segmentation

9.1. Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pre-Filled Syringes, Multi-Dose Vials

9.2. Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Influenza Prevention

9.3. Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Retail Pharmacies, Government Supplier

9.4. Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Geriatric

10. Afluria Market Regional And Country Analysis

10.1. Global Afluria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Afluria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Afluria Market

11.1. Asia-Pacific Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Afluria Market

12.1. China Afluria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Afluria Market

13.1. India Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Afluria Market

14.1. Japan Afluria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Afluria Market

15.1. Australia Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Afluria Market

16.1. South Korea Afluria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Afluria Market

17.1. Western Europe Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Afluria Market

18.1. UK Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Afluria Market

19.1. Germany Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Afluria Market

20.1. France Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Afluria Market

21.1. Eastern Europe Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Afluria Market

22.1. North America Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Afluria Market

23.1. USA Afluria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Afluria Market

24.1. Canada Afluria Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Afluria Market

25.1. South America Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Afluria Market

26.1. Middle East Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Afluria Market

27.1. Africa Afluria Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Afluria Market, Segmentation By Formulation, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Afluria Market Regulatory and Investment Landscape

29. Afluria Market Competitive Landscape And Company Profiles

29.1. Afluria Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Afluria Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Afluria Market Company Profiles

29.3.1. CSL Seqirus Overview, Products and Services, Strategy and Financial Analysis

30. Global Afluria Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Afluria Market

32. Afluria Market High Potential Countries, Segments and Strategies

32.1 Afluria Market In 2030 - Countries Offering Most New Opportunities

32.2 Afluria Market In 2030 - Segments Offering Most New Opportunities

32.3 Afluria Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Afluria Market, Overview Of Key Products - Product Examples
  • Table 2: Global Afluria Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Afluria Market, Supply Chain Analysis
  • Table 4: Global Afluria Market, Major Raw Material Providers
  • Table 5: Global Afluria Market, Major Resource Providers
  • Table 6: Global Afluria Market, Major Manufacturers (Suppliers)
  • Table 7: Global Afluria Market, Major Distributors And Channel Partners
  • Table 8: Global Afluria Market, Key Technologies & Future Trends
  • Table 9: Global Afluria Market, Major Trends
  • Table 10: Global Afluria Market, Major End Users
  • Table 11: Global Afluria Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Afluria Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Afluria Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Afluria Market - TAM, US$ Billion, 2025
  • Table 15: Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Afluria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Afluria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Afluria Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Afluria Market - Company Scoring Matrix
  • Table 74: CSL Seqirus Financial Performance
  • Table 75: Global Afluria Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Afluria Market, Competitive Dashboard
  • Table 77: Global Afluria Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Afluria Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 79: Global, Afluria Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 80: Global, Afluria Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Afluria Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Afluria Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Afluria Market, Supply Chain Analysis
  • Figure 4: Global Afluria Market, Major Raw Material Providers
  • Figure 5: Global Afluria Market, Major Resource Providers
  • Figure 6: Global Afluria Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Afluria Market, Major Distributors And Channel Partners
  • Figure 8: Global Afluria Market, Key Technologies & Future Trends
  • Figure 9: Global Afluria Market, Major Trends
  • Figure 10: Global Afluria Market, Major End Users
  • Figure 11: Global Afluria Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Afluria Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Afluria Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Afluria Market - TAM, US$ Billion, 2025
  • Figure 15: Global Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Afluria Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Afluria Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Afluria Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Afluria Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Afluria Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Afluria Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Afluria Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Afluria Market - Company Scoring Matrix
  • Figure 74: CSL Seqirus Financial Performance
  • Figure 75: Global Afluria Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Afluria Market, Competitive Dashboard
  • Figure 77: Global Afluria Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Afluria Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 79: Global, Afluria Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 80: Global, Afluria Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Afluria market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Afluria market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Afluria market Include, CSL Seqirus .

Major trend in this market includes: Innovative Solutions In The Influenza Vaccine Market Enhanced Growth. For further insights on this market. request a sample here

North America was the largest region in the afluria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts